2-Bromo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine, 98%, 5g

N-[(3S)-2,6-DIOXOPIPERIDIN-3-YL]-2-PHENYLACETAMIDE, 98%, 10mg

5-Methyl-1-vinyl-1H-pyrazole-4-carbaldehyde, 95.0%, 1g

Narrow mouth bottle square, 2000 ml, 53 B, 1 Piece

[S(R)]-N-[(1S)-1-[2-((tert-Butyldiphenylsilyl)oxy)phenyl)]-2-yl-2-(diphenylphosphino)ethyl]-2-methyl-2-propanesulfinamide, 95%, 250mg

3-(4-Bromophenyl)-1-phenyl-1H-pyrazole-4-carboxaldehyde, 95.0%, 250mg

6-Methoxy-9H-purin-2-amine, 95.0%, 100g

4-Ethoxy-3,5-difluorophenylboronic acid, 97%, 10g

2-[(3-Fluorophenyl)methyl]isoindole-1,3-dione, 95%, 500mg

4-Chloro-2-(trifluoromethyl)quinoline>97.0%(GC)5g

6-Fluoronaphthalen-1-amine, 98%, 500mg

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate, 95.0%, 5g

4-(2-Chloro-thiazol-5-ylmethyl)-piperazine-1-carboxylic acid tert-butyl ester, 250mg